Salmeterol is a new long-acting and highly selective &-agonist agent. Clinical studies have shown that it has a very long (at least 12 hours) duration of action in terms of its bronchodilator effect1 and that its effect on bronchial hyperresponsiveness may even be longer. In a recent study we showed that salmeterol administered in a single dose of 50 pg still had a complete blocking effect on hyperventilation-induced asthma in four of 12 subjects (one third) who were tested up to 12 hours later.’ The recommended dose of this preparation varies between 50 and 100 pg every 12 hours. The aim of this study was to expand our previous work on characterizing the magnitude and duration of action of inhaled salmetereol on hyperventilation-induced bronchoconstriction in a more detailed way, especially on the interval between 12 and 24 hours and later after its administration. We also wanted to compare the efficacy of two different doses, 50 and 100 pg. recent modification in their need for a bronchodilator) were included in the study. The project was accepted by a local ethics committee, and a written consent form was obtained from each participant.
Read full abstract